Analyst Ratings for Guardant Health (GH)
GH Rating Summary
GH Price Target Summary
- Highest: $215.00 (Citi)
- Lowest: $60.00 (Scotiabank)
- Average: $152.24
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$152.24 (+3.3%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
Avg. $ Target:
$152.24 (+3.3%)
* Over Last 12-Mos
Rating Score: 9 / 10
Percentile Rank: 89%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/25/2026 | Bernstein SocGen Group » Updated 7/2/2026 |
Eve Burstein | New Coverage | Outperform (N/A) |
200.00 (175.00) |
142.94 (147.33) |
3.07% | Details |
| 6/11/2026 | RBC Capital | Dan Leonard | New Coverage | Outperform (N/A) |
185.00 (N/A) |
130.70 (147.33) |
12.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
